» Articles » PMID: 36238043

Deep Learning in Thyroid Ultrasonography to Predict Tumor Recurrence in Thyroid Cancers

Overview
Specialty Radiology
Date 2022 Oct 14
PMID 36238043
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To evaluate a deep learning model to predict recurrence of thyroid tumor using preoperative ultrasonography (US).

Materials And Methods: We included representative images from 229 US-based patients (male:female = 42:187; mean age, 49.6 years) who had been diagnosed with thyroid cancer on preoperative US and subsequently underwent thyroid surgery. After selecting each representative transverse or longitudinal US image, we created a data set from the resulting database of 898 images after augmentation. The Python 2.7.6 and Keras 2.1.5 framework for neural networks were used for deep learning with a convolutional neural network. We compared the clinical and histological features between patients with and without recurrence. The predictive performance of the deep learning model between groups was evaluated using receiver operating characteristic (ROC) analysis, and the area under the ROC curve served as a summary of the prognostic performance of the deep learning model to predict recurrent thyroid cancer.

Results: Tumor recurrence was noted in 49 (21.4%) among the 229 patients. Tumor size and multifocality varied significantly between the groups with and without recurrence ( < 0.05). The overall mean area under the curve (AUC) value of the deep learning model for prediction of recurrent thyroid cancer was 0.9 ± 0.06. The mean AUC value was 0.87 ± 0.03 in macrocarcinoma and 0.79 ± 0.16 in microcarcinoma.

Conclusion: A deep learning model for analysis of US images of thyroid cancer showed the possibility of predicting recurrence of thyroid cancer.

Citing Articles

Radiomics Analysis of Gray-Scale Ultrasonographic Images of Papillary Thyroid Carcinoma > 1 cm: Potential Biomarker for the Prediction of Lymph Node Metastasis.

Chung H, Han K, Lee E, Yoon J, Park V, Lee M J Korean Soc Radiol. 2023; 84(1):185-196.

PMID: 36818698 PMC: 9935950. DOI: 10.3348/jksr.2021.0155.

References
1.
Mann B, Buhr H . Lymph node dissection in patients with differentiated thyroid carcinoma--who benefits?. Langenbecks Arch Surg. 1998; 383(5):355-8. DOI: 10.1007/s004230050148. View

2.
Ito Y, Miyauchi A, Kobayashi K, Miya A . Prognosis and growth activity depend on patient age in clinical and subclinical papillary thyroid carcinoma. Endocr J. 2013; 61(3):205-13. DOI: 10.1507/endocrj.ej13-0403. View

3.
Baek S, Jung K, Kang S, Kwon S, Woo J, Cho S . Clinical risk factors associated with cervical lymph node recurrence in papillary thyroid carcinoma. Thyroid. 2009; 20(2):147-52. DOI: 10.1089/thy.2008.0243. View

4.
Kim S, Kwak J, Kim E, Yoon J, Moon H . Association of Preoperative US Features and Recurrence in Patients with Classic Papillary Thyroid Carcinoma. Radiology. 2015; 277(2):574-83. DOI: 10.1148/radiol.2015142470. View

5.
Mazzaferri E, Jhiang S . Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med. 1994; 97(5):418-28. DOI: 10.1016/0002-9343(94)90321-2. View